GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BELLUS Health Inc (NAS:BLU) » Definitions » Days Sales Outstanding

BELLUS Health (BELLUS Health) Days Sales Outstanding : 25,139.38 (As of Mar. 2023)


View and export this data going back to 2000. Start your Free Trial

What is BELLUS Health Days Sales Outstanding?

BELLUS Health's average Accounts Receivable for the three months ended in Mar. 2023 was $0.83 Mil. BELLUS Health's Revenue for the three months ended in Mar. 2023 was $0.00 Mil. Hence, BELLUS Health's Days Sales Outstanding for the three months ended in Mar. 2023 was 25,139.38.

The historical rank and industry rank for BELLUS Health's Days Sales Outstanding or its related term are showing as below:

BLU' s Days Sales Outstanding Range Over the Past 10 Years
Min: 26.57   Med: 506.25   Max: 15057.47
Current: 15057.47

During the past 13 years, BELLUS Health's highest Days Sales Outstanding was 15057.47. The lowest was 26.57. And the median was 506.25.

BLU's Days Sales Outstanding is not ranked
in the Biotechnology industry.
Industry Median: 71.03 vs BLU: 15057.47

BELLUS Health's Days Sales Outstanding increased from Mar. 2022 (10,322.66) to Mar. 2023 (25,139.38).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.


BELLUS Health Days Sales Outstanding Historical Data

The historical data trend for BELLUS Health's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BELLUS Health Days Sales Outstanding Chart

BELLUS Health Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 933.56 2,392.78 6,886.33 7,915.94 11,771.25

BELLUS Health Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10,322.66 11,771.25 10,322.66 12,227.50 25,139.38

Competitive Comparison of BELLUS Health's Days Sales Outstanding

For the Biotechnology subindustry, BELLUS Health's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BELLUS Health's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BELLUS Health's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where BELLUS Health's Days Sales Outstanding falls into.



BELLUS Health Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

BELLUS Health's Days Sales Outstanding for the fiscal year that ended in Dec. 2022 is calculated as

Days Sales Outstanding (A: Dec. 2022 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2021 ) + Accounts Receivable (A: Dec. 2022 )) / count ) / Revenue (A: Dec. 2022 )*Days in Period
=( (0.369 + 0.663) / 2 ) / 0.016*365
=0.516 / 0.016*365
=11,771.25

BELLUS Health's Days Sales Outstanding for the quarter that ended in Mar. 2023 is calculated as:

Days Sales Outstanding (Q: Mar. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Mar. 2023 )) / count ) / Revenue (A: Mar. 2023 )*Days in Period
=( (0.663 + 0.99) / 2 ) / 0.003*365 / 4
=0.8265 / 0.003*365 / 4
=25,139.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BELLUS Health  (NAS:BLU) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


BELLUS Health Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of BELLUS Health's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


BELLUS Health (BELLUS Health) Business Description

Traded in Other Exchanges
N/A
Address
275 Armand-Frappier Boulevard, Laval, QC, CAN, H7V 4A7
BELLUS Health Inc is a clinical-stage biopharmaceutical development company advancing novel therapeutics for conditions with a high unmet medical need, including BLU-5937, a P2X3 antagonist that has the potential to be a best-in-class therapeutic for chronic cough. The company operates in one business segment namely, the development of drug candidates for health solutions.